Actionable NTM Answers
in Less Than 3 Days
NTM-Seq delivers rapid species-level identification and antimicrobial resistance insight direct from respiratory samples.
NTM Pulmonary Disease Is Rising. Current Diagnostics Haven't Kept Up.
The incidence of NTM pulmonary disease is increasing worldwide, yet diagnosis remains slow and imprecise. Traditional culture-based methods can take weeks to return results, and conventional identification often fails to distinguish between species — a critical gap when treatment regimens differ significantly between organisms like M. abscessus and M. avium complex.
NTM-Seq Results. One Test.
200+ NTM Species Detection
Broad coverage across the full spectrum of clinically relevant NTM species
Genotypic Resistance Characterization
Genomic markers for antimicrobial resistance to guide treatment selection
No Organism Growth Needed
Direct-from-sample testing eliminates the wait for culture
Better Information. Better Decisions.
Earlier Organism ID
Species-level identification in days instead of weeks
Earlier Resistance Insight
Genotypic resistance data before phenotypic testing is possible
Reduced Diagnostic Uncertainty
Comprehensive detection that doesn't miss rare or slow-growing species
Improved Treatment Confidence
Actionable data to support informed clinical decisions
NTM-Seq: Powered by
Next-Generation Sequencing
NTM-Seq analyzes all genetic material in a respiratory sample using advanced NGS technology — no culture step required.
Broad Species Coverage
Our curated database covers 200+ NTM species, including rare and emerging organisms that conventional methods miss.
Next-Generation Sequencing
Targeted NGS extracts and sequences DNA directly from respiratory samples, bypassing the slow culture step entirely.
Genomic Analysis
Bioinformatics pipelines scan for resistance-associated mutations and genes, providing genotypic insight alongside species ID.
Clear Reporting
Results are delivered in a clinician-friendly format with species identification, resistance markers, and clinical context.
From Sample to Actionable Report
Sample Collection
Respiratory sample is collected and submitted using standard clinical workflows.
Direct Sequencing
Genomic material is extracted and sequenced directly from the sample — no culture step, no waiting weeks.
Bioinformatics
Advanced computational analysis identifies NTM species and resistance markers from sequencing data.
Clinical Report
A clear, comprehensive report is delivered with species identification and treatment-relevant insights.
Built for the Clinicians and Labs
Fighting NTM Disease
Pulmonologists
Get species-level NTM identification to guide treatment decisions for patients with NTM pulmonary disease, bronchiectasis, and chronic lung infections.
Infectious Disease Specialists
Access genomic-level pathogen data and resistance insights to develop targeted antibiotic strategies and improve patient outcomes.
Clinical Microbiology Labs
Upgrade NTM identification workflows with NGS-based testing that delivers broader, more accurate species-level results.
Frequently Asked Questions
Interested in NTM-Seq?
We're working with clinicians and laboratories who are ready to move beyond the limitations of conventional NTM diagnostics. Get in touch to learn more.